Anti-FGF-23 Neutralizing Antibodies Ameliorate Muscle Weakness and Decreased Spontaneous Movement of Hyp MiceAONO, Yukiko; HASEGAWA, Hisashi; YAMAZAKI, Yuji et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 4, pp 803-810, issn 0884-0431, 8 p.Article

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolismSHIMADA, Takashi; VAMAZAKI, Yuji; FUKUMOTO, Seiji et al.American journal of physiology. Renal physiology. 2005, Vol 58, Num 5, pp F1088-F1095, issn 1931-857XArticle

Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23YAMAZAKI, Yuji; TAMADA, Taro; SHIMADA, Takashi et al.Journal of bone and mineral research (Print). 2008, Vol 23, Num 9, pp 1509-1518, issn 0884-0431, 10 p.Article

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney diseaseHASEGAWA, Hisashi; NAGANO, Nobuo; URAKAWA, Itaru et al.Kidney international. 2010, Vol 78, Num 10, pp 975-980, issn 0085-2538, 6 p.Article

Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatmentKURODA, Takeshi; TANABE, Naohito; SATO, Hiroe et al.Rheumatology international (Berlin. Print). 2006, Vol 26, Num 12, pp 1147-1153, issn 0172-8172, 7 p.Article

Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/OsteomalaciaAONO, Yukiko; YAMAZAKI, Yuji; SHIMADA, Takashi et al.Journal of bone and mineral research (Print). 2009, Vol 24, Num 11, pp 1879-1888, issn 0884-0431, 10 p.Article

Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V₂ receptor antagonistNAITO, Akira; HASEGAWA, Hisashi; KURASAWA, Takashi et al.Biological & pharmaceutical bulletin. 2001, Vol 24, Num 8, pp 897-901, issn 0918-6158Article

Serum soluble α-Klotho in hemodialysis patientsYOKOYAMA, Keitaro; IMURA, Akihiko; OHKIDO, Ichiro et al.Clinical nephrology. 2012, Vol 77, Num 5, pp 347-351, issn 0301-0430, 5 p.Article

Klotho converts canonical FGF receptor into a specific receptor for FGF23URAKAWA, Itaru; YAMAZAKI, Yuji; SHIMADA, Takashi et al.Nature (London). 2006, Vol 444, Num 7120, pp 770-774, issn 0028-0836, 5 p.Article

Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy : Its important role in serum phosphate regulationYAMASHITA, Hiroyuki; YAMAZAKI, Yuji; HASEGAWA, Hisashi et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 7, pp 4211-4215, issn 0021-972X, 5 p.Article

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasisSHIMADA, Takashi; HASEGAWA, Hisashi; YAMAZAKI, Yuji et al.Journal of bone and mineral research (Print). 2004, Vol 19, Num 3, pp 429-435, issn 0884-0431, 7 p.Article

The therapeutic efficacy of VP-343, a selective vasopressin V₂ receptor antagonist, in the experimental SIADH rat modelNAITO, Akira; HASEGAWA, Hisashi; KURASAWA, Takashi et al.Biological & pharmaceutical bulletin. 2000, Vol 23, Num 11, pp 1323-1327, issn 0918-6158Article